Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus
dc.contributor.author | Jones, Dorothy M. | |
dc.contributor.author | Esmaeil, Nadia | |
dc.contributor.author | Maren, Stephen | |
dc.contributor.author | Macdonald, Robert L. | |
dc.date.accessioned | 2009-03-23T18:55:45Z | |
dc.date.available | 2009-03-23T18:55:45Z | |
dc.date.issued | 2002-08 | |
dc.identifier.citation | Learning & Memory, 9:243-52 <http://hdl.handle.net/2027.42/61947> | en |
dc.identifier.uri | https://hdl.handle.net/2027.42/61947 | |
dc.description.abstract | Status epilepticus is usually initially treated with a benzodiazepine such as diazepam. During prolonged seizures, however, patients often lose their sensitivity to benzodiazepines, thus developing pharmacoresistant seizures. In rats, administration of LiCl followed 20-24 h later by pilocarpine induces a continuous, self-sustained, and reproducible form of status epilepticus that can be terminated with diazepam when it is administered soon after the pilocarpine injection. However, when administered after a 45 min delay, diazepam is less effective. Previous findings have suggested that the development of pharmacoresistance is related to the stage of status epilepticus. In the present study, we characterized the seizure stage-dependence of diazepam pharmacoresistance. Following administration of different doses of diazepam at varying time intervals after specific behaviorally- and electrographically-defined seizure stages, stage-, time-, and dose-dependent pharmacoresistance to diazepam developed. We also studied two other antiepileptic drugs commonly used in the treatment of status epilepticus, phenobarbital and phenytoin. Consistent with previous studies, our results indicated a similar relationship between stage, time and dose for phenobarbital, but not for phenytoin. Our data are consistent with rapid modulation of GABA(A) receptors during status epilepticus that may result in pharmacoresistance to antiepileptic drugs that enhance GABA(A) receptor-mediated inhibition. | en |
dc.format.extent | 304913 bytes | |
dc.format.mimetype | application/pdf | |
dc.language.iso | en_US | en |
dc.relation.ispartofseries | Stephen Maren | en |
dc.title | Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus | en |
dc.type | Article | en |
dc.subject.hlbsecondlevel | Psychology | |
dc.subject.hlbtoplevel | Social Sciences | |
dc.description.peerreviewed | Peer Reviewed | en |
dc.contributor.affiliationum | Psychology, Department of | en |
dc.contributor.affiliationum | Neuroscience Program | en |
dc.contributor.affiliationumcampus | Ann Arbor | en |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/61947/1/jonesER02.pdf | |
dc.owningcollname | Psychology, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.